Journal: Drug Invention Today

Article Id: JPRS-P col-00003222
Title: Nucleotide-binding and oligomerization domain-like receptor protein 3 inflammasome expression and activation in multiple sclerosis
Category: Pharmaceutics
Section: Research Article
  • Abstract
  • Audio Abstract
  • Authors
  • Pdf File
  • Citation
  • My Reference
  • Methodology
  • Abstract

    Aim: Inflammasome pathway has been linked in the pathogenesis of multiple sclerosis (MS) disease and its expression may be linked to the response to treatment. This study aims to evaluate inflammasome protein and mRNA expression and activating cytokines (interleukin [IL] 1B and IL18) in MS patients undergoing the first line and second line of treatment. Materials and Methods: In this study, 60 MS patients whom attended the MS clinic in the medical city of Baghdad. 30 from them on the first-line drug which includes interferon-beta and 30 on the second-line drugs which include fingolimod and natalizumab and 30 apparently healthy controls included in this study. Nucleotide-binding and oligomerization domain-like receptor protein 3 (NLRP3) mRNA expression was evaluated using quantitative real-time polymerase chain reaction and NLRP3, IL-18, and IL-1β plasma level were estimated by enzyme-linked immunosorbent assay. Results: This study found that the mRNA expression of NLRP3 was significantly higher in patients compared to controls (P < 0.001), as well as the plasma concentration of NLRP3, IL-18, and IL-1β was significantly higher in patients than controls (P < 0.001). In another hand, this study found that there is no significant difference in the expression of NLRP3 and the plasma level of NLRP3, IL-18, and IL-1β between patients who are on the first line and those on the second-line drugs (P = 0.382, 0.449, 0.197, and 0.327, respectively). Conclusion: The NLRP3 expression and activation might govern the inflammatory process in MS disease, and it might be affected equally by treatment with the first line and second line of treatment.

  • Abstract Audio

    No Audio file found

  • About the authors and Affiliations

    Author(s) Name:

    Raghda A. Hussein1 , Haider F. Ghazi 2 *, Nawfal M. Sheaheed3

    Affiliation(s) Name:

    1AL-Karama Teaching Hospital, Baghdad, Iraq,

    2 Department of Microbiology, College of Medicine, AL-Nahrain University, Baghdad, Iraq,

    3 Department of Neurology, Medical City, Ministry of Health, Baghdad, Iraq

    *Corresponding author: Dr. Haider F. Ghazi, Department of Microbiology, College of Medicine, AL-Nahrain University, Baghdad, Iraq

  • View Article File in pdf format.

    Article File
  • View Article Citation Here.

    0 View More
  • How to Cite my Article.

    Author:

    Raghda A. Hussein1 , Haider F. Ghazi 2 *, Nawfal M. Sheaheed3

    Title:Nucleotide-binding and oligomerization domain-like receptor protein 3 inflammasome expression and activation in multiple sclerosis
    Journal:Drug Invention Today
    Vol(issue):11 (March)
    Year:2019
    Page No: (614-620)
  • Experimental Methods Keywords

    Methodology: enzyme-linked immunosorbent assay
    Research Materials:60 Multiple sclerosis patients

Keywords

Inflammasome Multiple sclerosis and treatment Autoimmune-mediated illness Experimental autoimmune encephalomyelitis

Our Services

Most Downloaded List